Genentech/Roche is seeking a Principal Medical Director to join the Inflammatory Bowel Disease group within Product Development Immunology, Infectious Disease, and Ophthalmology. The individual will play a leadership role in developing and executing the long-range plans for etrolizumab, collaborating with early clinical development and partnering to advance molecules into the late stage portfolio, and shaping the company’s inflammatory bowel disease strategy. The Principal Medical Director for Inflammatory Bowel Disease (IBD) is expected to be a standing member of the Development Review Committee for molecules in this disease area. IBD is a disease area of high interest and investment at Roche. Roche has a rich IBD pipeline at various stages of development, including etrolizumab which has a large ongoing Phase 3 program, IL-22 which is currently in Phase 2b development, and multiple Phase 1 and research assets.
Broadly represent the interests of Product Development I2O Inflammatory Bowel Disease group within Roche and Genentech, as a member of the IBD Leadership Team, as well as through interactions with Research, Biomarkers, Early Development, Medical Affairs, Commercial, Regulatory Business Development, and Global Product Strategy senior leaders.
Design and develop, or oversee others in design and development of clinical studies
Provide strategic support for inflammatory bowel disease area strategies across all molecules
Closely interface with early development groups to define opportunities to explore new areas of scientific discovery
Provide strategic support for Late Stage partnering for opportunities in inflammatory bowel disease and other gastrointestinal diseases
Evaluate approved and late stage IBD molecules for new indication opportunities
Coach, manage, inspire and support employees to achieve business goals
Maintain and develop a positive organizational culture, by promoting the focus on patients, science, and our people
Maintain the highest standards and levels of scientific and clinical knowledge in the specific therapeutic and disease areas
Who You Are
MD or x-US equivalent with board certification or eligibility in Gastroenterology or a closely related field and substantial clinical drug development experience in inflammatory bowel disease
Noted disease expert with credibility to interface with key external health organizations
Clinical practice experience required and strong scientific competence demonstrated by peer-reviewed publications or production of clinical expert reports
Proven leadership skills, as evidenced by having managed people within a pharmaceutical company or in a clinical/academic environment
Minimum of 5 years experience in clinical research required, with experience collaborating closely with industry highly preferred
Ability to interact effectively in a multifunctional, multinational team setting
Strong interpersonal, influencing, presentation, and communications skills (written and verbal) to effectively address all levels within an organization
Who We Are
A member of the Roche Group, Genentech has been at the forefront of the biotechnology industry
for more than 40 years, using human genetic information to develop novel medicines for serious and
life-threatening diseases. Genentech has multiple therapies on the market for cancer & other serious
illnesses. Please take this opportunity to learn about Genentech where we believe that our employees
are our most important asset & are dedicated to remaining a great place to work.
The next step is yours. To apply today, click on the "Apply online" button.
Genentech is an equal opportunity employer & prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital & veteran status. For more information about equal employment opportunity, visit our Genentech Careers page.